Please use this identifier to cite or link to this item:
|Title:||Fenfluramine augmentation of clomipramine treatment of obsessive compulsive disorder.|
|Authors:||Judd, F K;Chua, P;Lynch, C;Norman, Trevor R|
|Affiliation:||University of Melbourne, Department of Psychiatry, Austin Hospital, Heidelberg, Vic.|
|Citation:||The Australian and New Zealand Journal of Psychiatry; 25(3): 412-4|
|Abstract:||Recently, much research interest has been directed to demonstrating a possible biological basis to obsessive compulsive disorder. In particular, dysregulation in brain serotonin is suggested to be important. Two cases are described in which fenfluramine, a presynaptic 5 HT-releasing agent and 5HT-reuptake inhibitor was used to augment clomipramine treatment for OCD.|
|Internal ID Number:||1958165|
Clomipramine.administration & dosage
Dose-Response Relationship, Drug
Drug Administration Schedule
Drug Therapy, Combination
Fenfluramine.administration & dosage
|Appears in Collections:||Journal articles|
Files in This Item:
There are no files associated with this item.
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.